Resmed Inc (NYSE: RMD). Meaningful positive changes in fundamentals have recently occurred: the consensus estimate for June, 2024 increased significantly, the stock’s power rating rose above 70, and the consensus estimate for June, 2025 increased significantly.
Significant positive changes in investment behavior have recently occurred for Resmed Inc (NYSE: RMD): the stock’s recent price rise disrupted its longer term downtrend.
In light of these very positive signals we are reviewing our current Overall Rating of C. We would view the shares with optimism pending completion of this review in the next several days.
Current PriceTarget Research Rating
With future capital returns forecasted to exceed the cost of capital, RMD is expected to continue to be a modest Value Builder.
Resmed has a current Value Trend Rating of C (Low Neutral). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Resmed has a very low Appreciation Score of 10 but a good Power Rating of 79, and the Low Neutral Value Trend Rating results.
Recent Price Action
Resmed Inc (NYSE: RMD) stock closed at $213.24 on 6/5/24 after a modest gain of 1.0%. However, this advance was accompanied by exceptionally low trading volume at 48% of normal. The stock has risen 2.9% during the last week and has been exceptionally strong relative to the market over the last nine months.
Be the first to comment